Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Determinants of Sustainable Return to Work After Burnout or Depression: A Longitudinal Cohort Study.

Journal of occupational rehabilitation·2026
Same author

Qualitative characterization of the composition of dental thermoplastic polymers by pyrolysis GC-MS.

Dental materials : official publication of the Academy of Dental Materials·2026
Same author

Understanding burnout and engagement during medical residency: a multifactorial and longitudinal approach.

BMC medical education·2026
Same author

Metabolic changes in human plasma samples among workers exposed to diisocyanate products.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026
Same author

Exposure of Farmers and Spouses to Glyphosate in Morocco: Urinary Levels and Predictors of Exposure.

Toxics·2026
Same author

Biomonitoring of Occupational Exposure to Mercury Among Dental Health Workers in LMICs: A Systematic Review.

International dental journal·2026

Related Experiment Video

Updated: Jan 15, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.2K

Method validation for quantification of five antineoplastic agents in urine using UPLC-ESI-MS/MS.

Eline Verscheure1, Dina Vandervoort1, Emily Deruyck1

  • 1Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.

Archives of Toxicology
|October 16, 2025
PubMed
Summary

New methods accurately measure hazardous antineoplastic agents in urine, crucial for monitoring patient and cohabitant exposure during home cancer treatment. This ensures safer at-home care for vulnerable populations.

Keywords:
Anticancer drugBiomonitoringChemical exposureLiquid chromatographyMass spectrometryTrace analysis

More Related Videos

Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
08:41

Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications

Published on: July 14, 2017

9.9K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.4K

Related Experiment Videos

Last Updated: Jan 15, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

10.2K
Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications
08:41

Integration of Miniaturized Solid Phase Extraction and LC-MS/MS Detection of 3-Nitrotyrosine in Human Urine for Clinical Applications

Published on: July 14, 2017

9.9K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.4K

Area of Science:

  • Occupational Health
  • Analytical Chemistry
  • Pharmacology

Background:

  • Antineoplastic agents are hazardous, posing occupational risks in hospitals.
  • Increased at-home cancer treatment necessitates monitoring for patient and cohabitant exposure.
  • Existing monitoring methods are insufficient for high-risk compounds in home environments.

Purpose of the Study:

  • To develop and validate sensitive methods for quantifying specific antineoplastic agents in urine.
  • To address the need for exposure assessment in home-based cancer treatment settings.

Main Methods:

  • Developed two validated methods for quantifying five high-risk antineoplastic agents (cyclophosphamide, etoposide, mitomycin C, imatinib, alpha-fluoro-beta-alanine) in urine.
  • Utilized liquid-liquid extraction and solid-phase extraction for sample preparation.
  • Employed ultra-high-performance liquid chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS) for analysis.

Main Results:

  • Methods were validated for selectivity, efficiency, linearity, sensitivity, precision, and accuracy.
  • Established lower limits of quantification ranging from 0.1 ng/mL to 10 ng/mL for the target agents.
  • Validated methods are ready for practical application in assessing occupational and home exposure.

Conclusions:

  • The developed urine-based analytical methods are highly sensitive and validated for quantifying key antineoplastic agents.
  • These methods are essential for monitoring exposure risks associated with at-home cancer therapy.
  • Implementation of these methods can enhance safety for patients and their cohabitants in non-clinical settings.